Operating Expenses: The sum of all operating expenses for the given industry.
Eli Lilly and Company (LLY) had Operating Expenses of $38.88B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$65.18B |
|
$20.64B |
|
$11.05B |
|
$54.13B |
|
|
Operating Expenses |
$38.88B |
$26.30B |
|
$-571.00M |
|
$25.73B |
|
$25.73B |
|
$20.64B |
|
$20.64B |
|
$20.64B |
|
$20.64B |
|
$26.30B |
|
$28.30B |
|
897.30M |
|
899.30M |
|
$23.00 |
|
$22.95 |
|
| Balance Sheet Financials | |
$55.63B |
|
$24.68B |
|
$56.85B |
|
$112.48B |
|
$35.23B |
|
$40.87B |
|
$50.71B |
|
$85.94B |
|
$26.54B |
|
$14.12B |
|
$26.54B |
|
944.80M |
|
| Cash Flow Statement Financials | |
$16.81B |
|
$-10.97B |
|
$-2.21B |
|
$3.27B |
|
$7.27B |
|
$4.00B |
|
$626.00M |
|
$-5.38B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.58 |
|
-- |
|
-- |
|
0.61 |
|
1.60 |
|
83.04% |
|
40.35% |
|
40.35% |
|
43.42% |
|
39.48% |
|
31.67% |
|
$8.97B |
|
-- |
|
-- |
|
-- |
|
0.58 |
|
0.80 |
|
3.23 |
|
112.87 |
|
77.78% |
|
146.22% |
|
18.35% |
|
30.62% |
|
$28.09 |
|
$9.98 |
|
$18.70 |
|